Trellus Health

TRLS · AIM · Health Care · mcap £0.5m · 0.1p

Beta Briefing, track record and bull & bear case are not ready for Trellus Health yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 29 companies are already wired into a briefing: browse them.

All announcements Monitoring checked today, 21:05

All · 39 Key · 21

Date	Type	Announcement	Day
24 Aug 26		Appointment of Administrators & Nomad Resignation Further to the notification of 21 August 2026, the Board of Trellus Health has today appointed Paul Zalkin and Tom Parish of Quantuma Advisory Ltd as joint administrators of the Company (the "Joint Administrators").	+0.0%
21 Aug 26		Notice of intention to appoint Administrators Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions	+0.0%
12 Aug 26		Loan and Related Party Transaction Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions	+0.0%
31 Jul 26		Update Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions	+0.0%
06 Jul 26		Trellus Health Further to the notice released on 08 June 2026 , the following company has been suspended 40 business days without indication of resumption.	+0.0%
30 Jun 26	Results	Delay to Publication of Annual Report and Accounts Delay to Publication of Annual Report and Accounts	+0.0%
19 Jun 26		Update Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions	+0.0%
08 May 26		Suspension - Trellus Health Plc At the request of the Company, trading on AIM for the under-mentioned securities was temporarily suspended from 08/05/2026 7:30am, pending clarification of the Company's financial position.	+0.0%
08 May 26		Update on Funding & Suspension of Trading Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions	+0.0%
28 Apr 26	Routine	Issue of Equity - Conversion of Loan Notes
15 Apr 26	Routine	Issue of Equity - Conversion of Loan Notes
13 Apr 26		Pfizer Licensing Agreement Renewal Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions	+25.0%
08 Apr 26	Routine	Issue of Equity - Conversion of Loan Notes
02 Apr 26		Funding Update Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions	+0.0%
27 Mar 26		MSA Signed and Funding Update Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions	−18.2%
18 Mar 26	Routine	Issue of Equity - Conversion of Loan Notes
13 Mar 26	Holding	Holding(s) in Company
13 Mar 26	Holding	Holding(s) in Company
10 Mar 26	Holding	Holding(s) in Company
10 Mar 26	Routine	Issue of Equity - Conversion of Loan Notes
02 Mar 26	Routine	Issue of Equity - Conversion of Loan Notes
26 Feb 26	Holding	Holding(s) in Company
23 Feb 26	Routine	Issue of Equity
18 Feb 26		Contract Extension with Johnson & Johnson Contract Extension with Johnson & Johnson Health Care Systems	+111.1%
18 Feb 26	Routine	Issue of Equity - Conversion of Loan Notes
11 Feb 26	Routine	Issue of Equity
06 Feb 26	Holding	Holding(s) in Company
03 Feb 26	Holding	Holding(s) in Company
03 Feb 26	Holding	Holding(s) in Company
03 Feb 26		Business update Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions	−21.1%
29 Jan 26		Grant of Share Options Trellus Health® plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programs and value-based solutions	−7.0%
22 Jan 26	Holding	Holding(s) in Company
20 Jan 26	Routine	Result of Meeting
19 Jan 26		Grant of Share Options Trellus Health® plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programs and value-based solutions	+0.0%
30 Dec 25		Proposed issue of Secured Convertible Loan Notes IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED	+0.0%
24 Nov 25		Finance update Trellus Health® plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programs and value-based solutions	+23.8%
07 Nov 25		Contract signed with second leading CRO Trellus Health® plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programs and value-based solutions	+0.0%
22 Oct 25		Contract Signed with Leading Global CRO The Contract is due to commence later this year.	+0.0%
21 Oct 25		Company Update Trellus Health® plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programs and value-based solutions	−13.3%

Company filings. Not investment advice.